Literature DB >> 6133988

Measures to prevent cervical injury during suction curettage abortion.

K F Schulz, D A Grimes, W Cates.   

Abstract

Cervical injury is one of the most frequent complications of suction curettage abortion, yet little is known about its risk factors or prevention. In 15 438 suction curettage abortions carried out at less than or equal to 12 weeks' gestation in hospitals in the USA from 1975 to 1978 the incidence of cervical injury requiring suturing was 1.03 per 100 abortions. Among factors potentially within the physician's control, use of laminaria rather than rigid dilators for dilatation had a strong protective effect (relative risk 0.19), whereas performance of the abortion by a resident rather than an attending physician (relative risk 2.0) and use of general rather than local anaesthesia (relative risk 2.6) had detrimental effects on rates of cervical injury. Among other factors, a previous abortion had a protective effect (relative risk 0.46), whereas patient age less than or equal to 17 years had a detrimental effect (relative risk 1.9). Use of laminaria, performance of the abortion by an attending physician, and local anaesthesia together yield a 27-fold protective effect.

Entities:  

Keywords:  Abortion History; Abortion, Induced; Age Factors; Anesthesia; Biology; Cannula; Cervical Effects; Cervix; Cohort Analysis; Curettage--complications; Data Analysis; Delivery Of Health Care; Ethnic Groups; Family Planning; Fertility Control, Postconception; Genitalia; Genitalia, Female; Health; Health Personnel; Health Services; Incidence; Laminaria Tents; Measurement; Medicine; Multivariate Analysis; Obstetrical Surgery; Parity; Physicians; Physiology; Preventive Medicine; Prospective Studies; Research Methodology; Statistics; Studies; Surgery; Treatment; Urogenital System; Uterus

Mesh:

Year:  1983        PMID: 6133988     DOI: 10.1016/s0140-6736(83)92464-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

Review 1.  Mifepristone. Separating fact from fiction.

Authors:  R C Henshaw; A A Templeton
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

2.  Safety of aspiration abortion performed by nurse practitioners, certified nurse midwives, and physician assistants under a California legal waiver.

Authors:  Tracy A Weitz; Diana Taylor; Sheila Desai; Ushma D Upadhyay; Jeff Waldman; Molly F Battistelli; Eleanor A Drey
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

3.  General anaesthesia, a risk factor for complication following induced abortion?

Authors:  J F Osborn; E Arisi; A Spinelli; M A Stazi
Journal:  Eur J Epidemiol       Date:  1990-12       Impact factor: 8.082

Review 4.  Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  R N Brogden; K L Goa; D Faulds
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

5.  Early abortion in family medicine: clinical outcomes.

Authors:  Ian M Bennett; Margaret Baylson; Karin Kalkstein; Ginger Gillespie; Scarlett L Bellamy; Joan Fleischman
Journal:  Ann Fam Med       Date:  2009 Nov-Dec       Impact factor: 5.166

6.  Uses of misoprostol in obstetrics and gynecology.

Authors:  Rebecca Allen; Barbara M O'Brien
Journal:  Rev Obstet Gynecol       Date:  2009

7.  Prostaglandin-induced cervical remodelling in humans in the first trimester is associated with increased expression of specific tight junction, but not gap junction proteins.

Authors:  Vidita V Ghulé; Colin Gray; Andrea Galimberti; Dilly O C Anumba
Journal:  J Transl Med       Date:  2012-03-07       Impact factor: 5.531

8.  A combination of misoprostol and estradiol for preoperative cervical ripening in postmenopausal women: a randomised controlled trial.

Authors:  K S Oppegaard; M Lieng; A Berg; O Istre; E Qvigstad; B-I Nesheim
Journal:  BJOG       Date:  2010-01       Impact factor: 6.531

9.  Continuous controllable balloon dilation: a novel approach for cervix dilation.

Authors:  Slobodan Arsenijevic; Gordana Vukcevic-Globarevic; Vladislav Volarevic; Ivan Macuzic; Petar Todorovic; Irena Tanaskovic; Milan Mijailovic; Sasa Raicevic; Branislav Jeremic
Journal:  Trials       Date:  2012-10-22       Impact factor: 2.279

10.  Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design.

Authors:  K S Oppegaard; B-I Nesheim; O Istre; E Qvigstad
Journal:  BJOG       Date:  2008-01-16       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.